- Japan
- /
- Electronic Equipment and Components
- /
- TSE:6961
Enplas Second Quarter 2025 Earnings: EPS: JP¥65.20 (vs JP¥120 in 2Q 2024)
Enplas (TSE:6961) Second Quarter 2025 Results
Key Financial Results
- Revenue: JP¥9.10b (down 4.1% from 2Q 2024).
- Net income: JP¥576.0m (down 46% from 2Q 2024).
- Profit margin: 6.3% (down from 11% in 2Q 2024). The decrease in margin was primarily driven by lower revenue.
- EPS: JP¥65.20 (down from JP¥120 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Enplas Earnings Insights
Looking ahead, revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Electronic industry in Japan.
Performance of the Japanese Electronic industry.
The company's shares are down 3.1% from a week ago.
Risk Analysis
It is worth noting though that we have found 1 warning sign for Enplas that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if Enplas might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:6961
Enplas
Manufactures and sells semiconductor, automobile parts, optical communication devices, and life science related products in Japan and internationally.
Flawless balance sheet and undervalued.